Cardlytics Balance Sheet Health
Financial Health criteria checks 3/6
Cardlytics has a total shareholder equity of $64.1M and total debt of $213.9M, which brings its debt-to-equity ratio to 333.8%. Its total assets and total liabilities are $369.1M and $305.0M respectively.
Key information
333.82%
Debt to equity ratio
US$213.95m
Debt
| Interest coverage ratio | n/a |
| Cash | US$52.05m |
| Equity | US$64.09m |
| Total liabilities | US$304.98m |
| Total assets | US$369.07m |
Recent financial health updates
Is Cardlytics (NASDAQ:CDLX) Using Debt Sensibly?
Jul 05
Cardlytics (NASDAQ:CDLX) Has Debt But No Earnings; Should You Worry?
Mar 11Is Cardlytics (NASDAQ:CDLX) Using Too Much Debt?
Oct 15Would Cardlytics (NASDAQ:CDLX) Be Better Off With Less Debt?
Jan 04We Think Cardlytics (NASDAQ:CDLX) Has A Fair Chunk Of Debt
Oct 05Does Cardlytics (NASDAQ:CDLX) Have A Healthy Balance Sheet?
Jun 18Recent updates
Is Cardlytics (NASDAQ:CDLX) Using Debt Sensibly?
Jul 05Cardlytics, Inc. (NASDAQ:CDLX) Soars 30% But It's A Story Of Risk Vs Reward
May 29Cardlytics: Underrecognized Margin Recovery; Strong Buy Reiterated
May 26Why Investors Shouldn't Be Surprised By Cardlytics, Inc.'s (NASDAQ:CDLX) 30% Share Price Plunge
Apr 07
US Neobank And Taiwan Office Will Unlock New Markets
Expansion into new sectors and partnerships with financial institutions and neobanks is expected to diversify the customer base and boost revenue.Cardlytics (NASDAQ:CDLX) Has Debt But No Earnings; Should You Worry?
Mar 11Revenues Tell The Story For Cardlytics, Inc. (NASDAQ:CDLX)
Feb 21Cardlytics: Short-Term Headwinds Drive Long-Term Success
Feb 13At US$3.35, Is It Time To Put Cardlytics, Inc. (NASDAQ:CDLX) On Your Watch List?
Jan 10Cardlytics Continues Revenue Contraction Amid Worsening Economics
Dec 07Estimating The Intrinsic Value Of Cardlytics, Inc. (NASDAQ:CDLX)
Nov 23After Leaping 27% Cardlytics, Inc. (NASDAQ:CDLX) Shares Are Not Flying Under The Radar
Nov 05Is Cardlytics (NASDAQ:CDLX) Using Too Much Debt?
Oct 15Cardlytics: Execution Risks Are Elevated, But Reasons For Optimism Remain (Maintain Hold Rating)
Sep 17Cardlytics, Inc.'s (NASDAQ:CDLX) 63% Share Price Plunge Could Signal Some Risk
Aug 09Cardlytics: Has Multiple Potential Growth Levers, But Persistent Risks Remain
Jul 02Cardlytics, Inc.'s (NASDAQ:CDLX) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors
May 31The Power Of Cardlytics' Data Partnerships Including Bank of America
Apr 17Cardlytics, Inc.'s (NASDAQ:CDLX) 81% Jump Shows Its Popularity With Investors
Apr 10Cardlytics: Good Prospects But Macro Uncertain
Feb 16Cardlytics, Inc.'s (NASDAQ:CDLX) 29% Share Price Plunge Could Signal Some Risk
Jan 18Would Cardlytics (NASDAQ:CDLX) Be Better Off With Less Debt?
Jan 04We Think Cardlytics (NASDAQ:CDLX) Has A Fair Chunk Of Debt
Oct 05Does Cardlytics (NASDAQ:CDLX) Have A Healthy Balance Sheet?
Jun 18Cardlytics, Inc. (NASDAQ:CDLX) Stock Rockets 105% But Many Are Still Ignoring The Company
Apr 17Financial Position Analysis
Short Term Liabilities: CDLX's short term assets ($156.8M) exceed its short term liabilities ($131.9M).
Long Term Liabilities: CDLX's short term assets ($156.8M) do not cover its long term liabilities ($173.1M).
Debt to Equity History and Analysis
Debt Level: CDLX's net debt to equity ratio (252.6%) is considered high.
Reducing Debt: CDLX's debt to equity ratio has increased from 0% to 333.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CDLX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: CDLX has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 10.4% each year
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/20 19:13 |
| End of Day Share Price | 2025/07/18 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cardlytics, Inc. is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Omar Dessouky | BofA Global Research |
| Jason Kreyer | Craig-Hallum Capital Group LLC |
| Robert Coolbrith | Evercore ISI |